Multiple Sclerosis Market Report 2018 - Epidemiology Forecast 2016-2027 - ResearchAndMarkets.com

DUBLIN--()--The "Multiple Sclerosis -Epidemiology Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Multiple Sclerosis - Epidemiology Forecast to 2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Multiple Sclerosis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

The disease epidemiology covered in the report is segmented by Gender [male/female], age group [19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and 80 years], sub-types [Relapsing Remitting MS, Primary Progressive MS and Progressive relapsing MS] and Expanded disability status scale (EDSS) [0.0-1.5, 2.0-3.5, 4.0-5.5, 6.0-7.5 and 8.0-9.5], thus presenting overall detailed analysis of the patient pool characteristics.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Key Topics Covered:

1. Report Introduction

2. Multiple Sclerosis Epidemiology Overview at a Glance

3. Disease Background and Overview: Multiple Sclerosis (MS)

4. Epidemiology and Patient Population

5. Epidemiology of Multiple Sclerosis

6. United States

7. Germany

8. France

9. Italy

10. Spain

11. United Kingdom

12. Japan

13. Unmet Needs

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/958xs5/multiple?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs